MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling

Cell Cycle

Volumn 11, Issue 4, 2012, Pages 767-777

  Lai, Vien Khach ^a   Ashraf, Muhammad ^a   Jiang, Shujia ^a   Haider, Khawaja Husnain ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Akt; Angiopoietin 1; microRNA; Proliferation; Stem cells

Indexed keywords

ANGIOPOIETIN 1; BROXURIDINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; KI 67 ANTIGEN; MICRORNA; MICRORNA 143; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOLOGY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MITOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WILD TYPE;

RATTUS;

EID: 84863393700     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.4.19211     Document Type: Article

References (39)

1. Niagara MI, Haider HKh, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007; 100:545-55; PMID:17234963; http://dx.doi.org/10.1161/01.RES. 0000258460.41160.ef.
2. + stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 2009; 119:2587-96; PMID:19414636; http://dx.doi.org/10. 1161/CIRCULATIONAHA.108.827691.
3. Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR- 210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009; 284:33161-8; PMID:19721136; http://dx.doi.org/10. 1074/jbc.M109.020925.
4. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008; 29:1807-18; PMID:18523058; http://dx.doi.org/10.1093/eurheartj/ehn220.
5. Yau TM, Kim C, Li G, Zhang Y, Weisel RD, Li RK. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 2005; 112:123-8; PMID:16159803.
6. Haider HKh, Jiang S, Idris NM, Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 2008; 103:1300-8; PMID:18948617; http://dx.doi.org/10.1161/CIRCRESAHA.108. 186742.
7. Jiang S, Haider HKh, Idris NM, Salim A, Ashraf M. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 2006; 99:776-84; PMID:16960098; http://dx.doi.org/10.1161/01.RES.0000244687.97719.4f.
8. Shujia J, Haider HK, Idris NM, Lu G, Ashraf M. Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res 2008; 77:525-33; PMID:18032392; http://dx.doi.org/10.1093/cvr/ cvm077.
9. Salih DA, Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 2008; 20:126-36; PMID:18394876; http://dx.doi.org/10.1016/j.ceb.2008.02.005.
10. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994; 14:1669-79; PMID:8114703.
11. Ito T, Yagi S, Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 2010; 398:735-40; PMID:20627091; http://dx.doi.org/10.1016/j.bbrc.2010.07.012.
12. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, et al. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) 2010; 2:415-31; PMID:20634564.
13. Brett JO, Renault VM, Rafalski VA, Webb AE, Brunet A. The microRNA cluster miR-106b∼25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation. Aging (Albany NY) 2011; 3:108-24; PMID:21386132.
14. Sayed D, Abdellatif M. AKT-ing via microRNA. Cell Cycle 2010; 9:3213-7; PMID:20814244; http://dx.doi.org/10.4161/cc.9.16.12634.
15. 1-S transition and promote rapid proliferation. Nat Genet 2008; 40:1478-83; PMID:18978791; http://dx.doi.org/10.1038/ng.250.
16. Xia W, Li J, Chen L, Huang B, Li S, Yang G, et al. MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol Cell Biochem 2010; 344:261-6; PMID:20683643; http://dx.doi.org/10.1007/s11010- 010-0550-2.
17. Peck B, Schulze A. A role for the cancer-associated miR-106b∼25 cluster in neuronal stem cells. Aging (Albany NY) 2011; 3:329-31; PMID:21483041.
18. He L, He X, Lowe SW, Hannon GJ. microRNAs join the p53 network - another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007; 7:819-22; PMID:17914404; http://dx.doi.org/10.1038/nrc2232.
19. Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A, Bello AM, et al. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 2011; 30:275-86; PMID:20956945; http://dx.doi.org/10.1038/onc.2010.416.
20. Lichner Z, Páll E, Kerekes A, Pállinger E, Maraghechi P, Bosze Z, et al. The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells. Differentiation 2011; 81:11-24; PMID:20864249; http://dx.doi.org/10.1016/j.diff. 2010.08.002.
21. Khwaja A. Akt is more than just a Bad kinase. Nature 1999; 401:33-4; PMID:10485701; http://dx.doi.org/10.1038/43354.
22. Roy SK, Srivastava RK, Shankar S. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal 2010; 5:10; PMID:20642839; http://dx.doi.org/10.1186/1750-2187-5-10.
23. Wang H, Cui J, Bauzon F, Zhu L. A comparison between Skp2 and FOXO1 for their cytoplasmic localization by Akt1. Cell Cycle 2010; 9:1021-2; PMID:20160512; http://dx.doi.org/10.4161/cc.9.5.10916.
24. Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 2004; 380:297-309; PMID:15005655; http://dx.doi.org/10.1042/ BJ20040167.
25. Cameron SJ, Abe J, Malik S, Che W, Yang J. Differential role of MEK5alpha and MEK5beta in BMK1/ERK5 activation. J Biol Chem 2004; 279:1506-12; PMID:14583600; http://dx.doi.org/10.1074/jbc.M308755200.
26. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci 2007; 120:2479-87; PMID:17646672; http://dx.doi.org/10.1242/jcs.001222.
27. Zhang H. Skip the nucleus, AKT drives Skp2 and FOXO1 to the same place? Cell Cycle 2010; 9:868-9; PMID:20348850; http://dx.doi.org/10.4161/cc.9.5.11153.
28. Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, Washko D, et al. The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development 2010; 137:1887-96; PMID:20460367; http://dx.doi.org/10.1242/dev. 050526.
29. Lee SK, Teng Y, Wong HK, Ng TK, Huang L, Lei P, et al. MicroRNA-145 regulates human corneal epithelial differentiation. PLoS One 2011; 6:21249; PMID:21701675; http://dx.doi.org/10.1371/journal.pone.0021249.
30. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460:705-10; PMID:19578358.
31. Dijckmeester WA, Wijnhoven BP, Watson DI, Leong MP, Michael MZ, Mayne GC, et al. MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus. J Gastrointest Surg 2009; 13:846-53; PMID:19190970; http://dx.doi.org/10.1007/s11605-009-0799-5.
32. Liu SP, Fu RH, Yu HH, Li KW, Tsai CH, Shyu WC, et al. MicroRNAs regulation modulated self-renewal and lineage differentiation of stem cells. Cell Transplant 2009; 18:1039-45; PMID:19523330; http://dx.doi.org/10.3727/ 096368909X471224.
33. Wang X, Hu G, Zhou J. Repression of versican expression by microRNA-143. J Biol Chem 2010; 285:23241-50; PMID:20489207; http://dx.doi.org/10.1074/jbc. M109.084673.
34. Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ, Lee JD. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 1998; 395:713-6; PMID:9790194; http://dx.doi.org/10.1038/27234.
35. Cameron SJ, Malik S, Akaike M, Lerner-Marmarosh N, Yan C, Lee JD, et al. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J Biol Chem 2003; 278:18682-8; PMID:12637502; http://dx.doi.org/10.1074/jbc.M213283200.
36. Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, et al. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 2009; 4:7542; PMID:19855844; http://dx.doi.org/10. 1371/journal.pone.0007542.
37. Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, et al. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res 2010; 70:2105-14; PMID:20179208; http://dx.doi.org/10.1158/0008-5472.CAN-08-1108.
38. Li Z, Wang C, Prendergast GC, Pestell RG. Cyclin D1 functions in cell migration. Cell Cycle 2006; 5:2440-2; PMID:17106256; http://dx.doi.org/10.4161/ cc.5.21.3428.
39. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 2011; 11:558-72; PMID:21734724; http://dx.doi.org/10.1038/nrc3090.